• Tweet
• Share
• Email this.

Market trends are beginning to support a western orientation for companies as they meet standards and prices enabling them to compete with recent industry leaders in India and China.

“Over the past two years in Russia and Ukraine, producers of pharmaceutical substances and those engaged in contract manufacturing have observed a slow uptrend. Previously those countries tried to be independent or be supplied from factories located in former Soviet Republics, such as the Baltic States. Now they have changed their market strategies and increasingly want to provide services to firms in Western countries. Their offers might be competitive to Indian and Chinese companies, as firms from the analysed region are today endeavouring to comply with internationally recognized standards, such as GMP.”

In order to locate and capitalize on new opportunities, you need direct access to the latest news, sharpest analysis, most reliable statistics and knowledgeable trends forecasting available. Read Pharmaceutical contract manufacturing and API sourcing in Russia, Ukraine and the Baltic States 2011 today, and refer to this new report from PMR on a regular basis as you monitor market expansion and contemplate new business strategies.

This report performs several extensive SWOT analyses – of the region, as compared to Far Eastern competition, of each individual country covered by the report, and of the top companies with the necessary certifications and available production capacities to classify as competitive enough to attract western partnership and investment. Key market drivers to outsourced contract manufacturing and API substance supply are catalogued and analysed, along with the accompanying impediments to successful and profitable contract fulfillment.

The document points out potential opportunities among competitors for profitable manufacturing opportunities in both chemically based and biological drugs, as well as for the manufacturing of the associated API. It explores current trends that have initiated market changes and predicts where today’s trends will take the pharmaceutical outsourcing industry in the future, taking into account impending regulatory changes and macroeconomic situations as they exist in each country.

Detailed company profiles act as a directory for those seeking capable partnership for new endeavors, providing contact and financial information, data on certification levels, industry experience, and production capacity, previous product history and additional service offerings.

While preparing Pharmaceutical contract manufacturing and API sourcing in Russia, Ukraine and the Baltic States 2011 , PMR’s expert analysts have consulted their most reliable sources and created a market guide that answers the questions of readers on all major issues with regard to both the current status and future progression of this dynamic marketplace.
Please visit placelinkhere.com to learn more about current and forecast conditions in the private healthcare market in Poland.